<?xml version="1.0" encoding="UTF-8"?>
<drug type="biotech" created="2015-12-01" updated="2019-12-02">
  <drugbank-id primary="true">DB10311</drugbank-id>
  <name>Human papillomavirus type 33 L1 capsid protein antigen</name>
  <description>Human papillomavirus type 33 L1 capsid protein antigen is contained in Gardasil is a vaccine for intramuscular injection. It is an immunization for young men and women 9-26 years of age for the prevention of diseases caused by Human Papillomavirus (HPV) type 33. The vaccine is prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Type 33 which are produced by separate fermentations in recombinant *Saccharomyces cerevisiae* and self-assembled into VLPs.</description>
  <cas-number/>
  <unii>759RAC446C</unii>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication/>
  <pharmacodynamics/>
  <mechanism-of-action/>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">L1 protein, Human papillomavirus type 33 Vaccine</synonym>
    <synonym language="english" coder="">Recombinant human papillomavirus type 33 L1 protein</synonym>
  </synonyms>
  <products>
    <product>
      <name>Gardasil 9</name>
      <labeller>Merck Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02437058</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-03-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Intramuscular</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Gardasil 9</name>
      <labeller>Merck Sharp &amp; Dohme Corp.</labeller>
      <ndc-id/>
      <ndc-product-code>0006-4119</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-12-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, suspension</dosage-form>
      <strength/>
      <route>Intramuscular</route>
      <fda-application-number>BLA125508</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Gardasil 9</name>
      <labeller>Merck Sharp &amp; Dohme Corp.</labeller>
      <ndc-id/>
      <ndc-product-code>0006-4121</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-12-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, suspension</dosage-form>
      <strength/>
      <route>Intramuscular</route>
      <fda-application-number>BLA125508</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Gardasil 9</name>
      <labeller>A-S Medication Solutions</labeller>
      <ndc-id/>
      <ndc-product-code>50090-2443</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-12-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, suspension</dosage-form>
      <strength/>
      <route>Intramuscular</route>
      <fda-application-number>BLA125508</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Gardasil 9</name>
      <ingredients>Human papillomavirus type 11 L1 capsid protein antigen + Human papillomavirus type 16 L1 capsid protein antigen + Human papillomavirus type 18 L1 capsid protein antigen + Human papillomavirus type 31 L1 capsid protein antigen + Human papillomavirus type 33 L1 capsid protein antigen + Human papillomavirus type 45 L1 capsid protein antigen + Human papillomavirus type 52 L1 capsid protein antigen + Human papillomavirus type 58 L1 capsid protein antigen + Human papillomavirus type 6 L1 capsid protein antigen</ingredients>
    </mixture>
    <mixture>
      <name>Gardasil 9</name>
      <ingredients>Human papillomavirus type 11 L1 capsid protein antigen + Human papillomavirus type 16 L1 capsid protein antigen + Human papillomavirus type 18 L1 capsid protein antigen + Human papillomavirus type 31 L1 capsid protein antigen + Human papillomavirus type 33 L1 capsid protein antigen + Human papillomavirus type 45 L1 capsid protein antigen + Human papillomavirus type 52 L1 capsid protein antigen + Human papillomavirus type 58 L1 capsid protein antigen + Human papillomavirus type 6 L1 capsid protein antigen</ingredients>
    </mixture>
    <mixture>
      <name>Gardasil 9</name>
      <ingredients>Human papillomavirus type 11 L1 capsid protein antigen + Human papillomavirus type 16 L1 capsid protein antigen + Human papillomavirus type 18 L1 capsid protein antigen + Human papillomavirus type 31 L1 capsid protein antigen + Human papillomavirus type 33 L1 capsid protein antigen + Human papillomavirus type 45 L1 capsid protein antigen + Human papillomavirus type 52 L1 capsid protein antigen + Human papillomavirus type 58 L1 capsid protein antigen + Human papillomavirus type 6 L1 capsid protein antigen</ingredients>
    </mixture>
    <mixture>
      <name>Gardasil 9</name>
      <ingredients>Human papillomavirus type 11 L1 capsid protein antigen + Human papillomavirus type 16 L1 capsid protein antigen + Human papillomavirus type 18 L1 capsid protein antigen + Human papillomavirus type 31 L1 capsid protein antigen + Human papillomavirus type 33 L1 capsid protein antigen + Human papillomavirus type 45 L1 capsid protein antigen + Human papillomavirus type 52 L1 capsid protein antigen + Human papillomavirus type 58 L1 capsid protein antigen + Human papillomavirus type 6 L1 capsid protein antigen</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories/>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Injection, suspension</form>
      <route>Intramuscular</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Intramuscular</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <sequences/>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>22571</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>347910490</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>